Category Archives: NEWS

CBMNet and IBCarb awarded BBSRC International Workshop Award

BBSRC has identified industrial biotechnology and bioenergy as high-level priority areas in its Delivery Plan for 2016-2020. Supporting the BBSRC to achieve its strategic goals, this focused workshop will identify the science and technological barriers that need to be addressed in order to harness the potential of plant ‘cell factories’ for producing biopharmaceuticals. A CBMNet-driven symposium (Manchester, September 2017) brought together key players from Canada, the EU and the UK, to discuss scientific and commercial opportunities and challenges in this space. The goal now is to regroup, with a more focused set of individuals, to refine the landscape and to identify opportunities for collaborative R&D projects involving academia and industry in the UK and Canada. These aims are synergistic with those of CBMNet and IBCarb in the UK, and with the Canadian Glycomics Network, GlycoNet. Read more

Evaluation of UK Involvement with the Research Framework Programme and other European Research and Innovation Programmes

The Department of Business, Energy and Industrial Strategy (BEIS) has published a report entitled “Evaluation of UK Involvement with the Research Framework Programme and other European Research and Innovation Programmes“. The final report, which was originally commissioned by BEIS in 2015, mainly looks at the UK’s involvement in FP7, but also includes some very early conclusions for participation in Horizon 2020 (using data until February 2016). Furthermore, it includes the results of a survey, case studies on FP7 administration and feedback, which UKRO, together with and a number of subscribers, provided in late 2015. Read more

Biorefining Potential for Scotland, A new report from Zero Waste Scotland

In 2015, Scottish Enterprise published “The Biorefinery Roadmap for Scotland” on behalf of the Scottish Industrial Biotechnology Development Group (SIBDG), which sets out the key actions required to identify the barriers and risks faced by companies and potential investors to enable the more established biorefinery technologies. The Roadmap aims to increase industrial biotechnology turnover to £900 million by 2025. Read more

« Older Entries Recent Entries »